Acutus Medical announced a plan to increase adoption of its AcQMap cardiac arrhythmia mapping consoles, drive procedure-volume growth in specific geographic regions, and refine the “scope” of its product-development programs.
The company also plans to reduce its manufacturing operations, among other cost-cutting measures, to reduce its quarterly “cash-burn rate” by 30%-40% by the end of 2022. The changes will reduce...